Health

MGI Wins IBO Design Gold Award for DNBelab C4 Pocket Single-Cell Lab

SHENZHEN, China, Aug. 24, 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has been awarded Gold by Instrument Business Outlook (IBO) at the 2022 IBO Design Awards for the outstanding design and functionality of its DNBelab C4 Pocket Single-Cell Lab. "MGI...

2022-08-24 22:05 2444

CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

SHANGHAI, Aug. 24, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has announced the 2022 Interim Results. Business Highlights * CT053: comple...

2022-08-24 20:50 2793

Jacobio Pharma Announces 2022 Interim Results

Investment in R&D increased 26.3% to RMB 221 million. Recorded revenue was RMB 54.7 million. Global development of KRAS G12C inhibitor and other clinical stage drug candidates accelerated. Development started in new pre-clinical stage drug candidates, such as iADC (immunostimulatory antibody-dr...

2022-08-24 00:32 3032

I-Mab Announces Share Purchase Plans by the Company and the Senior Management

GAITHERSBURG, Md. and SHANGHAI, Aug. 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it plans to implement share repurchases...

2022-08-23 21:13 3280

Clarity advances to cohort 3 of the CL04 trial of SARTATE™ in paediatric neuroblastoma

Highlights * Cohort 2 completed in participants with neuroblastoma who received therapy with67Cu SARTATE™ at a dose of 175MBq/kg body weight * No Dose Limiting Toxicities (DLTs) have been reported in cohort 1 and cohort 2 * Safety Review Committee (SRC) has recommended the trial continues w...

2022-08-23 21:04 2816

BIORCHESTRA appointed Dr. Gabriel Helmlinger (Ph.D., DABT) as Head of Translational and Clinical Pharmacology, Toxicology

BOSTON, Mass., Aug. 23, 2022 /PRNewswire/ -- BIORCHESTRA, headquartered in Daejeon,South Korea, appointed Dr. Gabriel Helmlinger (Ph.D., D.A.B.T.) as Vice-President, Head of Translational & Clinical Pharmacology, Toxicology. Dr. Helmlinger brings 25 years of drug research and clinical development...

2022-08-23 20:00 2069

AESOP Technology Wins Coveted Place in Mayo Clinic Platform_Accelerate Program to Build Better AI Model for Healthcare

SAN FRANCISCO, Aug. 22, 2022 /PRNewswire/ -- AESOP Technology announced that they have been accepted into Mayo Clinic Platform_Accelerate , a 20-week...

2022-08-23 00:00 2311

Waterdrop Joins the United Nations Global Compact

BEIJING, Aug. 22, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH ), a l...

2022-08-22 22:00 2622

AVELOS THERAPEUTICS ANNOUNCES $8 MILLON SERIES A FUNDING ROUND

Seoul-Based Biotechnology Company to Use Financing for Expanding Oncology Drug Discovery and Development SEOUL, South Korea, Aug. 22, 2022 /PRNewswire/ -- Innovative biotechnology company specializing in new drug discovery and development, Avelos Therapeutics, has received a glowing endorsement ...

2022-08-22 20:00 1996

Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total

- Bringing Unprecedented Medical Experience by Strengthening Partnerships with Pharmaceutical Companies inJapan and U.S. to Build Medical Data Platform - TOKYO and SINGAPORE, Aug. 22, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for ever...

2022-08-22 14:00 2146

Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer

NEWARK, Del. and NANJING, China, Aug. 22, 2022 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a leading global R&D biotechnology company, today announced the appointment ofSteven Knapp, PharmD., as Chief Regulatory & Quality Officer. In this position, he is responsible for the strategic leadership...

2022-08-22 13:00 1770

United Imaging Healthcare Announces Listing of Initial Public Offering

--RMB Shares began trading on the Shanghai Stock Exchange's STAR Market, making United Imaging Healthcare its largest IPO this year. SHANGHAI, Aug. 22, 2022 /PRNewswire/ -- United Imaging Healthcare (SHSE: 688271), a leading global medical imaging and radiotherapy equipment company, began tradin...

2022-08-22 12:34 2110

Waterdrop Unveiled Its First Digital Employee Waterdrop Assistant

BEIJING, Aug. 19, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently announced that it officially launched its first digital employee "Waterdrop ...

2022-08-19 21:45 2723

I-Mab to Report Business and Corporate Updates and Financial Results for the Six Months Ended June 30, 2022 on August 30, 2022

-  Major updates will focus on global clinical development of core assets, upcoming milestones and financial results -  The Company will update on potential implementation of a comprehensive share purchase program by the Company and current shareholders -  Conference Calls Scheduled at 7:00 a.m....

2022-08-19 21:00 2205

AIRS Medical Raises $20M in Series B Funding

SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- AIRS Medical, a healthcare startup based inSouth Korea and a member of the Born2Global Centre, recently announced that it has raised approximately$20M in Series B funding. The round of Series B funding welcomed new investors Q Capital Partners and...

2022-08-19 21:00 2412

World's First CAR-T for NMOSD Treatment, IASO Biotherapeutics' Equecabtagene Autoleucel, Receives IND Approval by NMPA

SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 19, 2022 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, announced today that the Center for Drug ...

2022-08-19 18:41 1966

J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC

SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- J INTS BIO announced that it held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' on the sideline of the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, on 7th August. This follo...

2022-08-19 16:00 1096

Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal clinical trial ofEnsifentrine for the maintenance treatment of chronic obstructive pulmonary ...

2022-08-19 11:24 1602

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

Data results will be available in Q1 2023 GAITHERSBURG, Md. and SUZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Compa...

2022-08-18 23:46 1424

uLab Systems™ ranked in top 20% of the Inc. 5000 annual list of the fastest growing companies in America

MEMPHIS, Tenn., Aug. 18, 2022 /PRNewswire/ -- Inc. has recognized uLab Systems, the only orthodontic company ranked in the Health Products industry category, for the explosive growth of 832% from 2018 to 2021, thus assigning a rank within the top 20% of their annualInc. 5000 list. The Inc. list i...

2022-08-18 22:15 1706
1 ... 141142143144145146147 ... 280